RxDoctor Payments Data

Daniel Sze

Vascular & Interventional Radiology · Stanford, CANPI 1194882985

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $95,347 of the $134,564 with a category attached, or 70.9%. 19 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 31.8% of the total. Reporting peaked in 2020 at $42,224 and has fallen 85.2% since, to $6,234 in 2025. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$134,564in general payments, 2019–2025

Across 127 payments — averaging $1059.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$43K
  • Sirtex Medical Inc$33K
  • Boston Scientific$15K
  • Terumo Medical Corporation$14K
  • Varian Medical Systems, Inc.$10K
  • Trisalus Life Sciences, Inc.$10K
  • plus $10K from 13 others
$67,287in research payments, 2019–2025

Across 9 payments — averaging $7476.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merit Medical Systems Inc$57K
  • Biocompatibles UK Ltd$7K
  • Boston Scientific$2K

What the payments were for

  • Consulting fees$95,34771%
  • Speaking & faculty fees$14,62011%
  • Travel & lodging$17,83913%
  • Food & beverage$6,7585%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$134,564 in reported general payments places this provider in the 90th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$54,073
Medicare patients
90
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →